https://ipharmag.com/article/fda-approves-lilly-onswik-efsitora-weekly-insulin-type-2-diabetes iPharmag en 2026-09-26T12:44:48+00:00 FDA Approves Lilly’s Onswik, a Once-Weekly Insulin for Type 2 Diabetes https://ipharmag.com/article/apoe4-alzheimers-brain-blood-vessel-damage-reversible-mount-sinai iPharmag en 2026-09-26T12:44:48+00:00 Alzheimer’s Top Risk Gene Scars the Brain’s Blood Vessels — and in Mice, It Could Be Reversed https://ipharmag.com/article/cancerguard-vs-galleri-multi-cancer-blood-tests-compared iPharmag en 2026-09-26T12:44:12+00:00 Cancerguard vs. Galleri: How the Two Multi-Cancer Blood Tests Compare